Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  SANOFI    SAN   FR0000120578

SANOFI (SAN)

2514
End-of-day quote. End-of-day quote TRADEGATE AG - 11/30
0.0000 EUR   0.00%
1d ago Power of 'France Inc' on display in Sanofi boardroom coup
1d ago Artificial hips business boosts Smith & Nephew profit
1d ago SANOFI : Restates Commitment to Nigeria, Africa
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Sanofi: Tests Show Zaltrap Improves Colorectal Cancer Survival Rate

10/08/2012 | 02:44am US/Eastern

French drug company Sanofi SA (>> SANOFI) Monday said results from the pivotal Phase III Velour study evaluating Zaltrap showed improvement in overall survival rate to colorectal cancer.

MAIN FACTS:

- Sanofi said the Journal of Clinical Oncology published the results of the study evaluating Zaltrap effects.

- In the Velour trial evaluating metastatic colorectal cancer patients previously treated with an oxaliplatin-containing regimen, Zaltrap in combination with the Folfiri chemotherapy regimen (5-fluorouracil, leucovorin, irinotecan) showed a statistically significant improvement in overall survival, progression-free survival, and the overall tumor response rate versus placebo plus Folfiri.

- The Velour data supported the regulatory approval of Zaltrap by the U.S. Food and Drug Administration (FDA) on August 3, 2012 after a Priority Review.

- Zaltrap is under review at the European Medicines Agency and other regulatory agencies worldwide, Sanofi says.

-Write to Inti Landauro at inti.landauro@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : SANOFI
Latest news on SANOFI
13h ago GENZYME : iTraumaCare Names Joseph Brennan as President and CEO
14h ago SANOFI : Merial Assigned Patent
1d ago Power of 'France Inc' on display in Sanofi boardroom coup
1d ago Artificial hips business boosts Smith & Nephew profit
1d ago SANOFI : Restates Commitment to Nigeria, Africa
2d agoDJADR Shares End Mixed; Sanofi, Banco Bilbao Vizcaya Argentaria Shares Fall
2d agoDJHealth Care Up on Earnings, Defensive Moves -- Health Care Roundup
2d ago SANOFI : Investigators at Sanofi Pasteur Report Findings in Vaccines (Advanced K..
2d ago Establishment of GPCR Consortium, a New International Partnership, to Advance..
2d ago French drugmaker Sanofi sacks CEO, shares drop
Advertisement
Chart
Duration : Period :
SANOFI Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF